Clinical Trial

Nitric Oxide Bioavailability and Early Life Stress (NO-Stress)

Study acronym: NO-Stress
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Cardiovascular disease is the leading cause of death in the United States. Other studies have shown that stress, early in life, could be a risk factor for cardiovascular disease, later in life. This study will look at the effect of early life stressors on your cardiovascular health.
Protocol Amendment History 14 amendments
This ClinicalTrials.gov record has been amended 14 times since 2014-04-15; most recent amendment 2025-01-27.
Status change: Enrolling by Invitation → Active, Not Recruiting 2022-07-18
Status change: Recruiting → Enrolling by Invitation 2019-01-08
Status change: Not Yet Recruiting → Recruiting 2014-12-09
Trial Details
NCT Number NCT02115724
Lead Sponsor Augusta University
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions Cardiovascular Disease
Enrollment 74 participants
Start Date 2014-04
Primary Completion 2026-12 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2025-01-28